-
1دورية أكاديمية
المؤلفون: Morton JI; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia. jedidiah.morton@baker.edu.au.; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia. jedidiah.morton@baker.edu.au., Ilomӓki J; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia., Magliano DJ; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia., Shaw JE; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
المصدر: Diabetologia [Diabetologia] 2021 Feb; Vol. 64 (2), pp. 349-360. Date of Electronic Publication: 2020 Oct 20.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0428 (Electronic) Linking ISSN: 0012186X NLM ISO Abbreviation: Diabetologia Subsets: MEDLINE
مواضيع طبية MeSH: Socioeconomic Factors*, Diabetes Mellitus, Type 2/*drug therapy , Dipeptidyl-Peptidase IV Inhibitors/*therapeutic use , Glucagon-Like Peptide-1 Receptor/*agonists , Healthcare Disparities/*statistics & numerical data , Hypoglycemic Agents/*therapeutic use , Rural Population/*statistics & numerical data , Sodium-Glucose Transporter 2 Inhibitors/*therapeutic use, Aged ; Australia ; Female ; Humans ; Male ; Middle Aged ; Neighborhood Characteristics/statistics & numerical data ; Registries ; Urban Population/statistics & numerical data ; Vulnerable Populations/statistics & numerical data
-
2دورية أكاديمية
المؤلفون: Manski-Nankervis JA; Department of General Practice, University of Melbourne, Carlton, Australia. jomn@unimelb.edu.au., Thuraisingam S; Department of General Practice, University of Melbourne, Carlton, Australia., Sluggett JK; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Australia., Kilov G; Department of General Practice, University of Melbourne, Carlton, Australia., Furler J; Department of General Practice, University of Melbourne, Carlton, Australia., O'Neal D; Department of Medicine, St Vincent's Hospital and University of Melbourne, Fitzroy, Australia.; Department of Endocrinology and Diabetes, St Vincent's Hospital, Fitzroy, Australia., Jenkins A; Department of Medicine, St Vincent's Hospital and University of Melbourne, Fitzroy, Australia.; Department of Endocrinology and Diabetes, St Vincent's Hospital, Fitzroy, Australia.; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Australia.
المصدر: BMC family practice [BMC Fam Pract] 2019 Feb 18; Vol. 20 (1), pp. 29. Date of Electronic Publication: 2019 Feb 18.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967792 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2296 (Electronic) Linking ISSN: 14712296 NLM ISO Abbreviation: BMC Fam Pract Subsets: MEDLINE
مواضيع طبية MeSH: General Practice*, Diabetes Mellitus, Type 2/*drug therapy , Dipeptidyl-Peptidase IV Inhibitors/*administration & dosage , Hypoglycemic Agents/*administration & dosage , Metformin/*administration & dosage , Renal Insufficiency, Chronic/*metabolism , Sodium-Glucose Transporter 2 Inhibitors/*administration & dosage , Sulfonylurea Compounds/*administration & dosage, Aged ; Aged, 80 and over ; Australia ; Cross-Sectional Studies ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/metabolism ; Female ; Glomerular Filtration Rate ; Glycated Hemoglobin/metabolism ; Humans ; Male ; Middle Aged ; Renal Insufficiency, Chronic/complications